Positive p53 Expression Is Associated with Primary Endocrine Therapy Resistance in Locally Advanced Stage Luminal B HER2-Negative Breast Cancer Patients: A Cross-Sectional Study in Indonesia

Luminal B HER2-negative breast cancer (BC) is the most common type in Indonesian BC patients, and frequently manifests with locally advanced staging. Recurrence often occurs within two years of the endocrine therapy course (primary endocrine therapy (ET) resistance). p53 mutation often exists in lum...

Descripción completa

Detalles Bibliográficos
Autores principales: Halim, Freda, Azhar, Yohana, Suwarman, Suwarman, Wahjoepramono, Eka Julianta, Hernowo, Bethy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252228/
https://www.ncbi.nlm.nih.gov/pubmed/37296690
http://dx.doi.org/10.3390/diagnostics13111838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252228/
https://www.ncbi.nlm.nih.gov/pubmed/37296690
http://dx.doi.org/10.3390/diagnostics13111838

Ejemplares similares